Revvity Phospho-Akt 1/2/3 (Ser473) Lance Ultra Tr-Fret

Revvity Please note control lysates are NOT included in kits. Control lysates are sold separately, catalog number TRF4002S. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity Formats: - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Our 500 assay point kit allows you to run 500 wells in 384-well format, using a 20 µL reaction volume. Our 10,000 assay point kit allows you to run 10,000 wells in 384-well format, using a 20 µL reaction volume.

Revvity LANCE^® and LANCE^® (Lanthanide chelate excite) Ultra are homogeneous (no wash) TR-FRET (time-resolved fluorescence resonance energy transfer) technologies. One antibody of interest is labeled with a donor fluorophore (a LANCE Europium chelate) and the second antibody is labeled with an acceptor fluorophore [ULight™ dye]. Upon excitation at 320 or 340 nm, energy can be transferred from the donor Europium chelate to the acceptor fluorophore if sufficiently close for FRET (~10 nm). This results in the emission of light at 665 nm. Data are represented as ratiometric (665/615 nm X 10,000). - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity AKT, also known as protein kinase B, is an important regulator of numerous cellular processes including cell survival, glucose metabolism, transcription, and apoptosis. AKT has three closely related isoforms (AKT1, AKT2, and AKT3), and these isoforms have been shown to act on both common and unique downstream substrates. AKT activation can be induced by a number of stimuli, whereby AKT is transported to membrane for phosphorylation. Activation occurs upon AKT phosphorylation of Thr308 by PDK1 and of Ser473 by mTORC2. AKT subsequently dissociates from the membrane and phosphorylates targets both in the cytoplasm, as well as, the cell nucleus. Deregulation of AKT has been implicated in a number of disease states including cancer, cardiovascular disease, and diabetes. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)